PA-PPG
PPG (NYSE:PPG) and the PPG Foundation today announced that they invested more than $17.5 million worldwide in 2023, an increase of $1.3 million over 2022. The funding supports more than 450 community partners and programs that are focused on advancing education and delivering community sustainability while encouraging PPG employee volunteerism.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240215307583/en/
PPG and the PPG Foundation invested more than $17.5 million worldwide in 2023 to support over 450 community partners and programs that are focused on advancing education and delivering community sustainability while encouraging PPG employee volunteerism. (Photo: Business Wire)
“In 2023, our purpose to ‘protect and beautify the world’ came to life across all areas of PPG’s community engagement investments. While our employees created colorful classrooms, our funding aimed to advance learning and inspire STEM careers,” said Malesia Dunn, executive director, PPG Foundation and corporate global social responsibility. “With new commitments in environmental sustainability education and workforce development, our priorities and giving centered around creating brighter communities for the future.”
Highlights of the 2023 community engagement commitments include:
-
$10.3 million to build the next generation of science, technology, engineering and mathematics (STEM) leaders.
- 2023 marked the five-year anniversary of the PPG SCIENCE PAVILION® at the Daniel G. and Carole L. Kamin Science Center (formerly Carnegie Science Center) in Pittsburgh.
- PPG launched a three-year partnership with the Finnish Science Centre Heureka to help fund Heureka’s new ‘Power of Play’ exhibition and color workshops for young students.
- PPG teamed up with programs such as Casa Hacker’s ‘Girls in Tech’ in Sumaré, Brazil, for students pursuing advanced STEM studies.
- Through its partnership with Give2Asia and Live2Give in China, PPG delivered the PPG Scholarship Program at eight universities and the PPG Career Intelligence Class in 15 universities.
- The PPG Foundation partnered with AdoptAClassroom.org to equip teachers and 10 schools in PPG communities with STEM education tools.
- In Soborg, Denmark, students visited PPG’s architectural coatings plant as part of Science Day and an ongoing partnership with STEM education group Naturvidenskabernes Hus.
-
Progress in DE&I, sustainability education and workforce development
- 89% progress made toward the commitment to invest $20 million by 2025 supporting programs for black communities and people of color in the U.S.
- PPG committed $5 million by 2030 to environmental sustainability education, supporting organizations such as National Environmental Education Foundation (NEEF) in the U.S. and the STEM Learning organization in the U.K.
- PPG also committed $2 million by 2025 for future skilled worker training through organizations including the Collision Repair Education Foundation (CREF) in the U.S. and donations of PPG MOONWALK® and PPG LINQ™ Pro educational tools to vocational schools in Europe.
-
$6.2 million to community sustainability and disaster and humanitarian relief:
- PPG and the PPG Foundation contributed to regional organizations supporting local emergency relief and recovery efforts, such as the Red Cross, following natural disasters in Acapulco, Mexico; Emilia-Romagna, Italy; Turkey; Slovenia; and Morocco.
-
60 COLORFUL COMMUNITIES® projects completed in 2023 in 16 countries:
- In 2023, PPG’s global Colorful Communities program reached its 500th project milestone. Since 2015, 26,500 PPG employee and community volunteers have positively impacted more than 9.2 million people in 50 countries.
- In 2023, PPG committed an additional $5 million to the Colorful Communities program through 2030, enabling PPG volunteers to incorporate new activities and elements into projects that focus on environmental sustainability.
- Throughout June, July and August 2023, the Colorful Communities program completed its second New Paint for a New Start initiative, transforming a total of more than 60 schools into engaging environments for 35,000 students.
Learn more about PPG and the PPG Foundation’s investments in 2023.
PPG’s global community engagement efforts and the PPG Foundation aim to bring color and brightness to PPG communities around the world. We invested more than $17.5 million in 2023, supporting hundreds of organizations across nearly 40 countries. By investing in educational opportunities, we help grow tomorrow’s STEM innovators and skilled workforce in fields related to coatings and manufacturing. Plus, we empower PPG employees to multiply their impact for causes that are important to them by supporting their volunteer efforts and charitable giving. Learn more here.
PPG: WE PROTECT AND BEAUTIFY THE WORLD®
At PPG (NYSE:PPG), we work every day to develop and deliver the paints, coatings and specialty materials that our customers have trusted for more than 140 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 70 countries and reported net sales of $18.2 billion in 2023. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com.
PPG LINQ is a trademark and Colorful Communities, MoonWalk, the PPG Logo and We protect and beautify the world are registered trademarks of PPG Industries Ohio, Inc.
CATEGORY Community Affairs
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240215307583/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press release
Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press release
Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus
Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press release
Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
